Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Denali Therapeutics Inc. | 31,897 | reported | 04 Nov 2025 | tx 2+42,529 |
| Lexeo Therapeutics, Inc. | 22,916 | reported | 26 Jun 2025 | tx 2+58,916 |
| RayzeBio, Inc. | 0 | reported | 26 Feb 2024 | tx 2+48,628−48,628 |
| iTeos Therapeutics, Inc. | 0 | reported | 13 May 2025 | tx 8+136,291−22,346 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 04 Nov 2025 | GRANT_AWARD | Denali Therapeutics Inc. | 10,632 | 0.00 USD | |
| 04 Nov 2025 | GRANT_AWARD | Denali Therapeutics Inc. | 31,897 | 0.00 USD | deriv |
| 26 Jun 2025 | GRANT_AWARD | Lexeo Therapeutics, Inc. | 22,916 | 0.00 USD | deriv |
| 13 May 2025 | EXERCISE | iTeos Therapeutics, Inc. | 22,346 | 4.30 USD | |
| 13 May 2025 | EXERCISE | iTeos Therapeutics, Inc. | 22,346 | 0.00 USD | deriv |
| 05 Jul 2024 | GRANT_AWARD | Lexeo Therapeutics, Inc. | 36,000 | 0.00 USD | deriv |
| 11 Jun 2024 | GRANT_AWARD | iTeos Therapeutics, Inc. | 24,200 | 0.00 USD | deriv |
| 26 Feb 2024 | OTHER | RayzeBio, Inc. | 48,628 | — | deriv |
| 01 Nov 2023 | GRANT_AWARD | RayzeBio, Inc. | 48,628 | 0.00 USD | deriv |
| 13 Jun 2023 | GRANT_AWARD | iTeos Therapeutics, Inc. | 22,383 | 0.00 USD | deriv |
| 09 Jun 2022 | GRANT_AWARD | iTeos Therapeutics, Inc. | 17,538 | 0.00 USD | deriv |
| 17 Jun 2021 | GRANT_AWARD | iTeos Therapeutics, Inc. | 16,608 | 0.00 USD | deriv |
| 23 Jul 2020 | GRANT_AWARD | iTeos Therapeutics, Inc. | 16,608 | 0.00 USD | deriv |